FDA Accepts Joenja sNDA for Lower-Weight Children With APDS and Grants Priority Review – Pharming
Pharming announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental New Drug Application (sNDA) seeking approval for lower doses of Joenja (leniolisib), an oral,… read more.
